Diagnosing and managing diabetic somatic and autonomic neuropathy
暂无分享,去创建一个
R. Malik | I. Petropoulos | U. Alam | G. Ponirakis | Hoda Gad | S. Azmi | M. Ferdousi | A. Kalteniece | Adnan Khan | H. Al-muhannadi | Abdulrahman Al-Mohamedi | Nebras H. Hadid | Salah Mahmoud | Harun Bhat | Alise Kalteniece | Adnan Khan
[1] R. Malik,et al. Faculty Opinions recommendation of Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[2] A. Lembo,et al. Prevalence of Chronic Constipation and Chronic Diarrhea in Diabetic Individuals in the United States , 2019, The American Journal of Gastroenterology.
[3] M. Tavakoli,et al. Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes , 2018, Diabetes Care.
[4] W. Hellstrom,et al. The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction. , 2018, The journal of sexual medicine.
[5] M. Hanefeld,et al. Sudomotor Testing of Diabetes Polyneuropathy , 2018, Front. Neurol..
[6] I. Wilkinson,et al. Reduced vitamin D levels in painful diabetic peripheral neuropathy , 2018, Diabetic medicine : a journal of the British Diabetic Association.
[7] R. Freeman,et al. Orthostatic Hypotension: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.
[8] L. Tarnow,et al. The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial , 2018, Diabetes Care.
[9] R. Malik,et al. Mirogabalin and emerging therapies for diabetic neuropathy , 2018, Journal of pain research.
[10] W. Hellstrom,et al. The 2018 Revision to the Process of Care Model for Evaluation of Erectile Dysfunction. , 2018, The journal of sexual medicine.
[11] N. Chaturvedi,et al. Explanations for less small fibre neuropathy in South Asian versus European subjects with type 2 diabetes in the UK , 2018, Diabetes/metabolism research and reviews.
[12] Sally A El Awdan,et al. Liraglutide ameliorated peripheral neuropathy in diabetic rats: Involvement of oxidative stress, inflammation and extracellular matrix remodeling , 2018, Journal of neurochemistry.
[13] R. Malik,et al. The Investigation and Treatment of Diabetic Gastroparesis. , 2018, Clinical therapeutics.
[14] O. Pedersen,et al. Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study , 2018, Diabetologia.
[15] R. Landgraf,et al. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). , 2018, Diabetes research and clinical practice.
[16] Norfleet B Thompson,et al. Carpal Tunnel Syndrome: Making Evidence-Based Treatment Decisions. , 2018, The Orthopedic clinics of North America.
[17] A. Heald,et al. British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction in Men-2017. , 2018, The journal of sexual medicine.
[18] T. Yong,et al. Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment , 2018, World journal of nephrology.
[19] A. Basit,et al. Improvement in Neuropathy Specific Quality of Life in Patients with Diabetes after Vitamin D Supplementation , 2017, Journal of diabetes research.
[20] R. Freeman,et al. NaV channel variants in patients with painful and nonpainful peripheral neuropathy , 2017, Neurology: Genetics.
[21] L. Dahlin,et al. Neurophysiological recovery 5 years after carpal tunnel release in patients with diabetes , 2017, Muscle & nerve.
[22] J. Rosenstock,et al. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study , 2017, Pain medicine.
[23] H. Hartung,et al. PERIPHERAL NEUROPATHIES: CIDP and other inflammatory neuropathies in diabetes — diagnosis and management , 2017 .
[24] K. D'Août,et al. Diabetic Neuropathy and Gait: A Review , 2017, Diabetes Therapy.
[25] P. Nett,et al. Diarrhea after bariatric procedures: Diagnosis and therapy , 2017, World journal of gastroenterology.
[26] H. Kaufmann. Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn? , 2017, Clinical Autonomic Research.
[27] P. Wiffen,et al. Tramadol for neuropathic pain in adults. , 2017, The Cochrane database of systematic reviews.
[28] P. Wiffen,et al. Gabapentin for chronic neuropathic pain in adults. , 2017, The Cochrane database of systematic reviews.
[29] F. Bowling,et al. Altered walking strategy and increased unsteadiness in participants with impaired glucose tolerance and Type 2 diabetes relates to small‐fibre neuropathy but not vitamin D deficiency , 2017, Diabetic medicine : a journal of the British Diabetic Association.
[30] R. Rosales,et al. Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys , 2017, Advances in Therapy.
[31] Andreas C. Themistocleous,et al. Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations , 2017, Pain.
[32] V. Spallone. Might genetics play a role in understanding and treating diabetic polyneuropathy? , 2017, Diabetes/metabolism research and reviews.
[33] A. Boulton,et al. Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study , 2017, Diabetologia.
[34] S. Dib-Hajj,et al. COL6A5 variants in familial neuropathic chronic itch , 2017, Brain : a journal of neurology.
[35] N. Calcutt,et al. Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy , 2017, Diabetes.
[36] R. Freeman,et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension , 2017, Journal of Neurology.
[37] R. Freeman,et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association , 2016, Diabetes Care.
[38] S. Hussain,et al. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review , 2016, The Clinical journal of pain.
[39] R. Kirsner,et al. Statins may be associated with six‐week diabetic foot ulcer healing , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[40] R. Malik,et al. Vitamin D and Diabetic Complications: True or False Prophet? , 2016, Diabetes Therapy.
[41] A. Basit,et al. Vitamin D for the treatment of painful diabetic neuropathy , 2016, BMJ Open Diabetes Research and Care.
[42] F. Bowling,et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels , 2016, Diabetes Care.
[43] K. Sango,et al. Efficacy of glucagon-like peptide-1 mimetics for neural regeneration , 2015, Neural regeneration research.
[44] S. Rajbhandari,et al. Prevalence of Painful Diabetic Neuropathy Using the Self-Completed Leeds Assessment of Neuropathic Symptoms and Signs Questionnaire in a Population with Diabetes. , 2015, Canadian journal of diabetes.
[45] P. Wiffen,et al. Amitriptyline for neuropathic pain in adults. , 2015, The Cochrane database of systematic reviews.
[46] K. Sango,et al. Neurotrophic and neuroprotective properties of exendin-4 in adult rat dorsal root ganglion neurons: involvement of insulin and RhoA , 2015, Histochemistry and Cell Biology.
[47] R. Malik,et al. Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy , 2015, Journal of diabetes research.
[48] A. Boulton,et al. Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes , 2015, Diabetes Care.
[49] Wei Tang,et al. Diabetic cystopathy: A review 综述:糖尿病性膀胱病 , 2015, Journal of diabetes.
[50] G. Kodumudi,et al. Tapentadol extended release in the management of peripheral diabetic neuropathic pain , 2015, Therapeutics and clinical risk management.
[51] A. Vinik,et al. A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy , 2014, Clinical Drug Investigation.
[52] I. Petropoulos,et al. The diagnostic accuracy of Neuropad® for assessing large and small fibre diabetic neuropathy , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[53] J. Rosenstock,et al. Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study , 2014, Diabetes Care.
[54] B. Nordestgaard,et al. Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study. , 2014, The lancet. Diabetes & endocrinology.
[55] S. Sindrup,et al. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study , 2014, PAIN®.
[56] G. Cruccu,et al. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study , 2014, PAIN®.
[57] R. Malik. Why are there no good treatments for diabetic neuropathy? , 2014, The lancet. Diabetes & endocrinology.
[58] A. Vinik,et al. A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy , 2014, Diabetes Care.
[59] A. Dahan,et al. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. , 2014, British journal of anaesthesia.
[60] A. Boulton,et al. Corneal Confocal Microscopy Detects Neuropathy in Subjects With Impaired Glucose Tolerance , 2014, Diabetes Care.
[61] R. Malik. Which Test for Diagnosing Early Human Diabetic Neuropathy? , 2014, Diabetes.
[62] A. Jacovides,et al. An epidemiological study to assess the prevalence of diabetic peripheral neuropathic pain among adults with diabetes attending private and institutional outpatient clinics in South Africa , 2014, The Journal of international medical research.
[63] L. Dahlin,et al. Molecular and pathological studies in the posterior interosseous nerve of diabetic and non-diabetic patients with carpal tunnel syndrome , 2014, Diabetologia.
[64] A. Tsapas,et al. A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis. , 2014, Metabolism: clinical and experimental.
[65] P. Wiffen,et al. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. , 2014, The Cochrane database of systematic reviews.
[66] J. Albers,et al. Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.
[67] N. Stone,et al. Statin use and lower extremity amputation risk in nonelderly diabetic patients. , 2013, Journal of vascular surgery.
[68] G. Cruccu,et al. Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain , 2013, PAIN®.
[69] M. B. Brown,et al. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial , 2013, Diabetologia.
[70] D. Kerr,et al. Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain , 2012, Diabetes Care.
[71] R. Hughes,et al. ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY , 2012, The Cochrane database of systematic reviews.
[72] G. Marfia,et al. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[73] G. Remuzzi,et al. Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial , 2011, Hypertension.
[74] A. Boulton,et al. Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[75] A. Boulton,et al. Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K. , 2011, Diabetes Care.
[76] K. Borch-Johnsen,et al. Prevalence of Neuropathy and Peripheral Arterial Disease and the Impact of Treatment in People With Screen-Detected Type 2 Diabetes , 2011, Diabetes Care.
[77] K. Abdalla,et al. Prevalence of Painful Diabetic Peripheral Neuropathy among Patients with Diabetes Mellitus in the Middle East Region , 2011, The Journal of international medical research.
[78] Rayaz A. Malik,et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.
[79] R. Freeman,et al. Diabetic Neuropathy , 2010, Diabetes Care.
[80] R. Freeman,et al. Quantification of sudomotor innervation: A comparison of three methods , 2010, Muscle & nerve.
[81] T. Alsaadi,et al. Guidelines for the Pharmacological Treatment of Peripheral Neuropathic Pain: Expert Panel Recommendations for the Middle East Region , 2010, The Journal of international medical research.
[82] N. Chaturvedi,et al. Explanations for the Lower Rates of Diabetic Neuropathy in Indian Asians Versus Europeans , 2010, Diabetes Care.
[83] J. Fleg,et al. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.
[84] S. Murao,et al. Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea , 2010, Diabetes Care.
[85] D. Giugliano,et al. Determinants of erectile dysfunction in type 2 diabetes , 2010, International Journal of Impotence Research.
[86] Rodica Pop-Busui,et al. Cardiac Autonomic Neuropathy in Diabetes , 2010, Diabetes Care.
[87] L. Dahlin,et al. Reduced myelinated nerve fibre and endoneurial capillary densities in the forearm of diabetic and non-diabetic patients with carpal tunnel syndrome , 2009, Acta Neuropathologica.
[88] W. Rathmann,et al. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre‐diabetes and diabetes. The KORA Myocardial Infarction Registry , 2009, European journal of pain.
[89] D. De Bacquer,et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. , 2009, Diabetes & metabolism.
[90] M. Laakso,et al. Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial , 2009, The Lancet.
[91] R. Freeman,et al. Quantification of sweat gland innervation , 2009, Neurology.
[92] S. K. Van Den Eeden,et al. Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes , 2009, Diabetes Care.
[93] J. Rosenstock,et al. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial , 2008, BMC neurology.
[94] N. Chaturvedi,et al. Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe , 2008, Diabetes Care.
[95] C. Sommer,et al. Small‐fibre involvement in diabetic patients with neuropathic foot pain , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[96] R. Freeman,et al. Neurogenic orthostatic hypotension. , 2008 .
[97] A. Boulton,et al. The Neuropad test: a visual indicator test for human diabetic neuropathy , 2008, Diabetologia.
[98] M. Barrot,et al. Delta-Opioid Receptors Are Critical for Tricyclic Antidepressant Treatment of Neuropathic Allodynia , 2008, Biological Psychiatry.
[99] O. Pedersen,et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.
[100] R. Freeman,et al. Clinical practice. Neurogenic orthostatic hypotension. , 2008, The New England journal of medicine.
[101] B. Yeap,et al. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study , 2008, Diabetologia.
[102] J. Singleton,et al. Impaired Glucose Tolerance and Neuropathy , 2008, The neurologist.
[103] Nathan Efron,et al. Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy , 2007, Diabetes.
[104] T. Harrison. Faculty Opinions recommendation of Lifestyle intervention for pre-diabetic neuropathy. , 2006 .
[105] D. Yue,et al. The relationship among pain, sensory loss, and small nerve fibers in diabetes. , 2006, Diabetes care.
[106] R. Freeman. Autonomic peripheral neuropathy , 2005, The Lancet.
[107] Nish Chaturvedi,et al. Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.
[108] R. Poole,et al. Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.
[109] S. Weigand,et al. Autonomic symptoms and diabetic neuropathy: a population-based study. , 2004, Diabetes care.
[110] R. Fisher,et al. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. , 2004, Gastroenterology.
[111] T. Nurmikko,et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[112] J. Rosenstock,et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.
[113] Misha-Miroslav Backonja,et al. Development of a Neuropathic Pain Questionnaire , 2003, The Clinical journal of pain.
[114] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[115] K. Demyttenaere,et al. Sexual dysfunction in women with type 1 diabetes: a controlled study. , 2002, Diabetes care.
[116] M. Bennett,et al. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs , 2001, Pain.
[117] K. Offord,et al. The Autonomic Symptom Profile , 1999, Neurology.
[118] W. Schady,et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial , 1998, The Lancet.
[119] E. Echevarría,et al. Effects of imipramine administration on mu-opioid receptor immunostaining in the rat forebrain. , 1998, Arzneimittel-Forschung.
[120] F. Gries,et al. Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study) , 1997, Diabetes Care.
[121] M. Harris,et al. Symptoms of Sensory Neuropathy in Adults with NIDDM in the U.S. Population , 1993, Diabetes Care.
[122] T. Takasu,et al. Characteristics of cranial nerve palsies in diabetic patients. , 1990, Diabetes research and clinical practice.
[123] K. Ogbonnaya,et al. Diabetic diarrhea. Pathophysiology, diagnosis, and management. , 1990, Archives of internal medicine.
[124] H. Fields,et al. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system , 1983, Annals of Neurology.
[125] M. Nassaji,et al. Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study. , 2017, Wounds : a compendium of clinical research and practice.
[126] R. Malik,et al. Wherefore Art Thou, O Treatment for Diabetic Neuropathy? , 2016, International review of neurobiology.
[127] R. Freeman,et al. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. , 2015, Brain : a journal of neurology.
[128] K. Borch-Johnsen,et al. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study , 2012, Diabetologia.
[129] J. Cappelleri,et al. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. , 2011, Pain medicine.
[130] J. Kusek,et al. The Effect of Intensive Glycemic Control and Diabetic Complications on Lower Urinary Tract Symptoms (LUTS) in Men with Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2009 .
[131] A. Sadosky,et al. A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, and Less Commonly Studied Neuropathic Pain Conditions , 2008, Pain practice : the official journal of World Institute of Pain.
[132] F. Gries,et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. , 1997, Diabetes care.
[133] H A Feldman,et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.